HR-5582 : Still Just a Bill

Abuse Deterrent Access Act of 2018

This bill requires the Centers for Medicare & Medicaid Services to report to Congress on the adequacy of access to abuse-deterrent opioid formulations for individuals with chronic pain enrolled in a prescription drug plan under Medicare or Medicare Advantage (MA). The report must account for any barriers preventing enrollees from accessing such formulations under Medicare or MA.

Action Timeline

Action DateTypeTextSource
2018-06-13IntroReferralReceived in the Senate and Read twice and referred to the Committee on Finance.Senate
2018-06-12FloorMotion to reconsider laid on the table Agreed to without objection.House floor actions
2018-06-12FloorOn motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5061)House floor actions
2018-06-12FloorDEBATE - The House proceeded with forty minutes of debate on H.R. 5582.House floor actions
2018-06-12FloorConsidered under suspension of the rules. (consideration: CR H5061-5063)House floor actions
2018-06-12FloorMr. Walden moved to suspend the rules and pass the bill, as amended.House floor actions
2018-06-08CalendarsPlaced on the Union Calendar, Calendar No. 556.House floor actions
2018-06-08DischargeCommittee on Ways and Means discharged.House floor actions
2018-06-08CommitteeReported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-721, Part I.House floor actions
2018-05-09CommitteeOrdered to be Reported (Amended) by Voice Vote.House committee actions
2018-05-09CommitteeCommittee Consideration and Mark-up Session Held.House committee actions
2018-05-01CommitteeReferred to the Subcommittee on Health.House committee actions
2018-04-23IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2018-04-23IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2018-04-23IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Health
See Subjects
  • Congressional oversight
  • Drug therapy
  • Drug trafficking and controlled substances
  • Drug, alcohol, tobacco use
  • Government studies and investigations
  • Health care costs and insurance
  • Health care coverage and access
  • Health promotion and preventive care
  • Medicare
  • Prescription drugs

Related Bills

See Related Bills